Share Email Print
cover

Proceedings Paper

Protein nanospheres: synergistic nanoplatform-based probes for multimodality imaging
Author(s): Michael A. McDonald; Paul C. Wang; Eliot L. Siegel
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

No single clinical imaging modality has the ability to provide both high resolution and high sensitivity at the anatomical, functional and molecular level. Synergistically integrated detection techniques overcome these barriers by combining the advantages of different imaging modalities while reducing their disadvantages. We report the development of protein nanospheres optimized for enhancing MRI, CT and US contrast while also providing high sensitivity optical detection. Transferrin protein nanospheres (TfpNS), silicon coated, doped rare earth oxide and rhodamine B isothiocyanate nanoparticles, Si⊂Gd2O3:Eu,RBITC, (NP) and transferrin protein nanospheres encapsulating Si⊂Gd2O3:Eu,RBITC nanoparticles (TfpNS-NP) were prepared in tissue-mimicking phantoms and imaged utilizing multiple cross-sectional imaging modalities. Preliminary results indicate a 1:1 NP to TfpNS ratio in TfpNS-NP and improved sensitivity of detection for MRI, CT, US and fluorescence imaging relative to its component parts and/or many commercially available contrast agents.

Paper Details

Date Published: 22 February 2011
PDF: 17 pages
Proc. SPIE 7910, Reporters, Markers, Dyes, Nanoparticles, and Molecular Probes for Biomedical Applications III, 79101G (22 February 2011); doi: 10.1117/12.876081
Show Author Affiliations
Michael A. McDonald, National Institute of Standards and Technology (United States)
Paul C. Wang, Howard Univ. (United States)
Eliot L. Siegel, Univ. of Maryland (United States)


Published in SPIE Proceedings Vol. 7910:
Reporters, Markers, Dyes, Nanoparticles, and Molecular Probes for Biomedical Applications III
Samuel Achilefu; Ramesh Raghavachari, Editor(s)

© SPIE. Terms of Use
Back to Top